Sun K - Search Results

1

Correction to: PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.

Zheng B, Ren T, Huang Y, Sun K, Wang S, Bao X, Liu K, Guo W. Zheng B, et al. Among authors: sun k. J Hematol Oncol. 2018 Mar 12;11(1):37. doi: 10.1186/s13045-018-0580-x. J Hematol Oncol. 2018. PMID: 29530070 Free PMC article.

2

PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.

Zheng B, Ren T, Huang Y, Sun K, Wang S, Bao X, Liu K, Guo W. Zheng B, et al. Among authors: sun k. J Hematol Oncol. 2018 Feb 6;11(1):16. doi: 10.1186/s13045-018-0560-1. J Hematol Oncol. 2018. PMID: 29409495 Free PMC article.

3

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.

Liu K, Ren T, Huang Y, Sun K, Bao X, Wang S, Zheng B, Guo W. Liu K, et al. Among authors: sun k. Cell Death Dis. 2017 Aug 24;8(8):e3015. doi: 10.1038/cddis.2017.422. Cell Death Dis. 2017. PMID: 28837148 Free PMC article.

4

BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.

Wang S, Ren T, Jiao G, Huang Y, Bao X, Zhang F, Liu K, Zheng B, Sun K, Guo W. Wang S, et al. Among authors: sun k. Oncotarget. 2017 Apr 24;8(35):58625-58641. doi: 10.18632/oncotarget.17382. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938584 Free PMC article.

5

BMPR2 and HIF1-α overexpression in resected osteosarcoma correlates with distant metastasis and patient survival.

Wang S, Ren T, Huang Y, Bao X, Sun K, Shen D, Guo W. Wang S, et al. Among authors: sun k. Chin J Cancer Res. 2017 Oct;29(5):447-454. doi: 10.21147/j.issn.1000-9604.2017.05.09. Chin J Cancer Res. 2017. PMID: 29142464 Free PMC article.

6

Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.

Zhang F, Yan T, Guo W, Sun K, Wang S, Bao X, Liu K, Zheng B, Zhang H, Ren T. Zhang F, et al. Among authors: sun k. J Exp Clin Cancer Res. 2018 Jul 3;37(1):135. doi: 10.1186/s13046-018-0791-6. J Exp Clin Cancer Res. 2018. PMID: 29970115 Free PMC article.

7

Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.

Xie L, Xu J, Sun X, Guo W, Gu J, Liu K, Zheng B, Ren T, Huang Y, Tang X, Yan T, Yang R, Sun K, Shen D, Li Y. Xie L, et al. Among authors: sun k, sun x. J Immunother Cancer. 2020 May;8(1):e000798. doi: 10.1136/jitc-2020-000798. J Immunother Cancer. 2020. PMID: 32376724 Free PMC article. Clinical Trial.

8

Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.

Bao X, Ren T, Huang Y, Sun K, Wang S, Liu K, Zheng B, Guo W. Bao X, et al. Among authors: sun k. Cell Death Dis. 2017 Feb 9;8(2):e2605. doi: 10.1038/cddis.2017.31. Cell Death Dis. 2017. PMID: 28182000 Free PMC article.

9

Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 beta.

Liang X, Guo W, Ren T, Huang Y, Sun K, Zhang H, Yu Y, Wang W, Niu J. Liang X, et al. Among authors: sun k. Cancer Lett. 2020 Jun 28;480:4-14. doi: 10.1016/j.canlet.2020.03.019. Epub 2020 Mar 24. Cancer Lett. 2020. PMID: 32220541

10

Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective study in two centres.

Xie L, Xu J, Sun X, Li X, Liu K, Liang X, Zhou Z, Zhuang H, Sun K, Wu Y, Gu J, Guo W. Xie L, et al. Among authors: sun k, sun x. Oncol Lett. 2021 Jul;22(1):552. doi: 10.3892/ol.2021.12813. Epub 2021 May 24. Oncol Lett. 2021. PMID: 34093773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,547 results

Search Page

Filters